C213240Level 4
Carboplatin/Durvalumab/Paclitaxel Regimen
**Semantic type:** Therapeutic or Preventive Procedure
**Definition:** A regimen consisting of carboplatin, durvalumab, and paclitaxel that may be used in the treatment of uterine neoplasms and non-small cell lung cancer (NSCLC).
**Synonyms:** - Carboplatin-Durvalumab-Paclitaxel - Carboplatin/Durvalumab/Paclitaxel - Carboplatin/Imfinzi/Paclitaxel - Carboplatin/Paclitaxel Plus Durvalumab - Carboplatin/Paclitaxel/Durvalumab - Durvalumab Plus Carboplatin/Paclitaxel - Paclitaxel/Carboplatin Plus Durvalumab - Paclitaxel/Carboplatin/Durvalumab
GET
/api/v1/systems/nci_thesaurus/nodes/C213240Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.